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Background: Clonal expansions of CD4 positive T large granular lymphocytes with or without co-expression of
CD8 are extremely uncommon. These typically display an indolent clinical course and are said to be associated with
other solid malignancies. We present the clinicopathologic features and immunophenotypic analyses of two rare
cases of CD4 positive T large granular lymphocyte proliferation with expression of natural killer cell associated
antigen CD56. Both had high positive anti cytomegalovirus (CMV) IgG titres and persistent lymphocytosis with a
relatively benign course at 15 and 13 months of follow up, respectively.
Case presentation:
Case 1
A 58 year old Indian man presented with fever and cough of one week duration. On examination, he was febrile
with crackles in the right lower zone. Hematological investigations revealed mild neutropenia and a monotypic
CD3 positive/CD4 positive/CD8 negative/CD56 positive/T cell receptor alpha-beta positive large granular lymphocyte
population representing 50% of blood and bone marrow lymphocytes. Clonality was demonstrated using a T
cell receptor gamma polymerase chain reaction. A chest roentgenogram showed features suggestive of
bronchopneumonia. Patient was treated with broad spectrum antibiotics and antipyretics with improvement.
At follow up of 15 months, he continued to have persistent large granular lymphocytosis.
Case 2
A 38 year old Indian woman presented with generalized weakness and malaise of two months duration. On
examination, she was afebrile with no lympadenopathy or hepatosplenomegaly. A routine hemogram showed
absolute lymphocytosis. Flow cytometric evaluation was performed on peripheral blood affirmed the cells to be
CD4 positive T large granular lymphocytes, with similar findings to the first case. At follow up of 13 months,
patient was otherwise asymptomatic but continued to have persistent CD4 positive large granular lymphocytosis.
Conclusions: Flow cytometric immunophenotyping remains an essential tool for the diagnosis of T cell
proliferations and helped to clinch the diagnosis in these cases. The aim of this case series is to present clinical and
immunophenotypic features of these rare CD4 positive T large granular lymphocyte proliferations that fulfil the
WHO defining criteria, however are better regarded as clonal expansions rather than as leukemias in view of their
indolent and non progressive nature.* Correspondence: renusaxena@outlook.com
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Figure 1 Peripheral smear. Peripheral smear showing large granular
lymphocytes (Jenner Giemsa, 100x).
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Large granular lymphocytes (LGL) comprise 10-15% of
peripheral blood mononuclear cells with absolute counts
in the range of 0.1-0.3 × 109/L. These are characterized by
high cytoplasmic: nuclear ratio and abundant azurophilic
granules [1,2]. LGL include both cytotoxic T lymphocytes
(CD3+) and natural killer(NK) cells (CD3−), both of which
serve as the main perpetrators of cell-mediated cytotox-
icity [3]. There are three notable variants of T-LGL
leukemia, based primarily on immunophenotypic differ-
ences. These are CD4−/CD8+, CD4−/CD8− or CD4+/
CD8−/+dim cells [4]. CD4+/CD8−/CD56+ T-LGL prolifera-
tions are rare and reported sporadically in case reports
[5,6] and small case series [7,8] in literature. These typic-
ally display an indolent clinical course and are said to be
associated with other solid malignancies. There is no ap-
parent association with rheumatoid arthritis or other auto-
immune diseases in contrast to the more common CD8+
T-LGL expansions [8].
It has been suggested that chronic antigenic stimulation
of T cells by cytomegalovirus (CMV) can lead to persistent
monoclonal expansions of CD4+/NK antigen+/CD8−/+dim
lymphocytes in patients having a particular HLA subtype
[9]. We report two cases of CD4+/CD8−/CD56+ T-LGL
proliferation that lacked hepatosplenomegaly and lymph-




A 58 year old male presented with fever and cough of one
week duration with associated generalized weakness, mal-
aise and increased fatigue of three months duration. On
examination he was febrile with temperature 100°F. Chest
examination revealed few crackles in the right lower zone.
No organomegaly or lympadenopathy were seen. A rou-
tine hemogram showed hemoglobin of 14.8 g/dL(13.5-
17 g/dL), leucocyte count of 26.88 × 109/L(4–11 × 109/L)
and platelet count of 210 × 109/L(150–400 × 109/L). The
absolute lymphocyte count was 23.65 × 109/L (1–3 ×
109/L) and absolute neutrophil count (ANC) was 1.34 ×
109/L (2–7 × 109/L). Peripheral smear showed 90% ma-
ture lymphoid cells, with most (75%) showing character-
istic large granular lymphocytic morphology (Figure 1).
Bone marrow (BM) aspirate smears were normocellular
and showed increased mature lymphoid cells (~45%).
BM biopsy sections showed normocellular marrow with
subtle interstitial lymphoid cell infiltrates that were
hardly discernible on morphology. Immunohistochem-
istry on bone marrow biopsy was not performed. A
chest roentgenogram showed features suggestive of
bronchopneumonia. Patient was seropositive for cyto-
megalovirus (CMV) IgG antibodies with high titres
(>250 AU/ml; non reactive <6 AU/ml). However, antiIgM CMV antibodies and serology for human immuno-
deficiency virus (HIV) and Ebstein Barr virus (EBV) were
negative. Rheumatoid factor, antinuclear antibodies, direct
and indirect Coomb’s tests were negative.
Immunophenotyping was performed on BD FACS
CantoTM flow cytometer and the analysis and interpret-
ation were carried out post-acquisition by BD FACS
Diva software (BD Biosciences, San Jose, CA). Fluores-
cence measurement was expressed as the percentage of
positive cells above a threshold set against a similarly
processed unstained tube acting as negative control.
Flow cytometry on BM aspirate showed large lymphoid
cluster of cells (~50% of all cells) with bright CD45 posi-
tivity. The cells were of T-cell origin and showed bright
positivity for CD3(99%), CD5(94%), CD2(99%), CD4
(90%), TCRαβ(95%) and CD56(87%) (Figure 2). CD7 ex-
pression was dim to weak seen in less than 20% cells.
CD8 expression and T cell receptor(TCR) γδ were nega-
tive. Other B lymphoid cell markers including CD10,
CD19, CD23, CD20, CD22, CD38, CD79b, CD103 and
CD11c and were negative. Monoclonal TCR γ chain
gene rearrangement was demonstrated by polymerase
chain reaction (PCR) amplification of genomic DNA. In
view of morphology, immunophenotypic findings and
monoclonality, a diagnosis of CD4+ /CD8− /CD56+ T-LGL
leukemia was established. Patient was treated with broad
spectrum antibiotics and antipyretics with improvement.
On follow up at 15 months patient was asymptomatic with
persistent lymphocytosis in the range of 12–19 × 109/L.
Case 2
A 38 year old female presented with generalized weakness
and malaise of two months duration. On examination she
was afebrile with no lympadenopathy or hepatosplenome-
galy. A routine hemogram showed hb of 12.4 g/dL(12–
15.3 g/dL), leucocyte count of 20.66 × 109/L(4–11 × 109/L)
Figure 2 Case 1. Flow cytometric immunophenotyping of bone marrow. Flow Cytometric Immunophenotyping of bone marrow aspirate
showing lymphocytes (red) expressing bright CD3(99%), CD4(90%), CD2(99%), CD5(94%), CD56(87%), TCRαβ(95%) and lack CD8, CD19, and TCRγδ.
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ipheral smear showed normocytic normochromic red cells,
lymphocytes 78%, with predominantly LGL morphology,
neutrophils 18%, monocytes 3% and eosinophil 1%. Flow
cytometric evaluation was performed on peripheral blood
affirmed the cells to be CD4+/CD8−/CD56+ T-LGLs, with
similar findings to the first case. Akin to the first case, CD7
expression was variable (dim to negative), seen in around
30% cells. Monoclonality was ascertained on TCR gene re-
arrangements by PCR. Erythrocyte sedimentation rate, C-
reactive protein and lactate dehydrogenase were within
normal limits. Rheumatoid factor and a panel of auto-
immune markers (antinuclear antibodies, anti double-
stranded desoxyribonucleic acid antibodies, SSA, SSB,
Sm, RNP, Scl-70 and Jo-1) were negative. Similar to the
first patient, anti CMV IgG antibodies were positive
with high titres (>250 AU/ml; non reactive < 6 AU/L)).
CMV IgM, HIV and EBV serology were negative. A BM
evaluation was not performed. At follow up of 13 months,
patient was otherwise asymptomatic but continued to
have persistent lymphocytosis in the range of 13–18 ×
109/L with LGL morphology and similar immunophenoty-
pic profile on repeat flow cytometry.
Discussion
The evidence of a peripheral blood LGL counts greater
than 2 × 109/L lasting for more than six months iscurrently regarded as the criteria to define the disease.
The World Health Organization (WHO) 2008 classifica-
tion segregates T-LGL leukemia from aggressive NK cell
leukemia and categorizes it in the subgroup of mature
peripheral T-cell neoplasms [10]. Immunophenotypically,
CD4+ T-LGL leukemia is a clonal expansion of granular
lymphocytes that co-express CD56 and CD57 NK-
associated antigens and variable levels of CD8 (CD8−/+dim)
[8]. It is different from typical CD8+ T-LGL leukemia as
most patients have normal findings on physical examin-
ation, with an indolent course. These patients lack neutro-
penia, anemia, and splenomegaly and an association with
autoimmune disorders in contrast with most CD8+ T-
LGL leukemias [6-8].
Both patients in this report had CD4+/CD8−/CD56+
T-LGL proliferation. CD7 expression was dim to nega-
tive in both cases. In a similar series of seven of eight
cases showed CD7 underexpression [7]. Thus, CD7 un-
derexpression could be regarded as a frequent aberrancy
in CD4+/CD8−/CD56+ T-LGL proliferation. The first pa-
tient in this report had an episode of mild neutropenia
(ANC < 1.5 × 109/L) at presentation associated with chest
infection, however, the second patient was asymptomatic,
but for non specific complaints of malaise and bodyache.
Some studies have suggested that activated CD4+/
CD8−/+dim/NK antigen+ T-LGL proliferations are effort
of the immune system to control tumor growth and are
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The associated neoplasia may appear after months to
years after the initial diagnosis, hence, it is vital to per-
form an extensive assessment for cancer and a close
follow-up of these patients. Both our patients had per-
sistent large granular lymphocytosis but showed no evi-
dence of any associated systemic malignancy at the end
of 15 and 13 months of follow up respectively. A longer
follow up may be required to ascertain this association.
Benign, reactive increases in LGLs are seen in associ-
ation with a variety of causes, including post-splenectomy,
allografts and chronic viral infections notably CMV [9,10].
Studies have shown that CMV seropositive immunocom-
petent healthy adults have oligoclonal expansions of CMV
specific CD4+/cytotoxic/memory T cells in the peripheral
blood thus providing evidence for involvement of CMV in
the ontogeny of CD4+ T-LGL [11]. Indian adult popula-
tion has a high seroprevalence of CMV as reported in
healthy blood donors (~95%) [12,13]. Hence, the associ-
ation of seropositivity for CMV with LGL proliferation in
our patients may be an occurrence by chance. Neverthe-
less, it cannot be ignored completely as both the patients
had very high anti CMV IgG titres and it is possible that a
latent CMV viral infection may have been responsible for
chronic immune activation and inflammation leading to
clonal expansion of CD4+ T-LGLs. This needs to be sub-
stantiated in larger studies on Indian population. Both our
patients have not been subjected to any further treatment
so far and are on close hematological and clinical follow
up to determine whether therapeutic intervention will be
necessary in future.
Conclusion
The aim of this case series is to present clinical and
immunophenotypic features of rare CD4 positive T-LGL
proliferations. Although these fulfil the WHO defining
criteria, we prefer to refer to them as clonal expansions
rather than as leukemias in view of their indolent and
non progressive nature, to avoid causing undue panic to
the patient. Flow cytometric immunophenotyping re-
mains an essential tool for the diagnosis.
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